Citations

Mayo Clinic

Clear

2362 citation(s) found for "JACK, N".

O2‐09‐03: Evidence of reduced neuronal plasticity to education in ApoE‐ɛ4 carriers
Overgaard, Shauna, Przybelski, Scott A. , Lowe, Val J. , Petersen, Ronald C. , Machulda, Mary M. , Mielke, Michelle M. , Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2015.07.179 Get It

P4‐053: Memory, executive, and multi‐domain subtle cognitive impairment: Clinical and biomarker finding
Bjerke, Maria , Rozycki, Martin, Weiner, Michael W. , Arnold, Steven E. , Reiman, Eric M. , Shaw, Leslie M. , Trojanowski, John Q. , Toledo, Jon B. , Chen, Kewei , Jack, Clifford R. , Davatzikos, Christos

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_17 | Pages: No page available

10.1016/j.jalz.2015.06.1758 Get It

Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer’s Disease: A Diffusion Tensor Imaging Study
Schwarz, Christopher G. , Drubach, Daniel A., Kantarci, Kejal , Przybelski, Scott A. , Senjem, Matthew L. , Gunter, Jeffrey L. , Apostolova, Liana G. , Lowe, Val J. , Petersen, Ronald C. , Jack, Clifford R. , Josephs, Keith A. , Whitwell, Jennifer L. , Madhavan, Ajay, Strand, Edythe A. , Madhavan, Ajay A. , Duffy, Joseph R. , Machulda, Mary M. , Reid, Robert I. , Jack, Clifford R , Schwarz, Christopher G , Senjem, Matthew L , Kantarci, Kejal

Journal of Alzheimer's Disease | December 14, 2015 | Volume: 49 | Issue: 3 | Pages: 633-643

10.3233/jad-150502 | PMID 26484918 Get It

Background: Different clinical syndromes can arise from Alzheimer’s disease (AD) neuropathology, including dementia of the Alzheimer’s type (DAT), logopenic primary progressive aphasia (lvPPA), and posterior cortical atrophy (PCA). Objective: To assess similarities and differences in patterns of white matter tract degeneration across these syndromic variants of AD. Methods: Sixty-four subjects (22 DAT, 24 lvPPA, and 18 PCA) that had diffusion tensor imaging and showed amyloid-β deposition on PET were assessed in this case-control study. A whole-brain voxel-based analysis was performed to assess differences in fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity across groups. Results: All three groups showed overlapping diffusion abnormalities in a network of tracts, including fornix, corpus callosum, posterior thalamic radiations, superior longitudinal fasciculus, inferior longitudinal fasciculus, inferior fronto-occipital fasciculus, and uncinate fasciculus. Subtle regional differences were also observed across groups, with DAT particularly associated with degeneration of fornix and cingulum, lvPPA with left inferior fronto-occipital fasciculus and uncinate fasciculus, and PCA with posterior thalamic radiations, superior longitudinal fasciculus, posterior cingulate, and splenium of the corpus callosum. Conclusion: These findings show that while each AD phenotype is associated with degeneration of a specific structural network of white matter tracts, striking spatial overlap exists among the three network patterns that may be related to AD pathology.
TRIM72 modulates caveolar endocytosis in repair of lung cells
Nagre, Nagaraja N. , Wang, Shaohua , Kellett, Thomas, Kanagasabai, Ragu, Deng, Jing, Nishi, Miyuki , Shilo, Konstantin , Oeckler, Richard A. , Yalowich, Jack C. , Takeshima, Hiroshi , Christman, John W. , Hubmayr, Rolf D., Zhao, Xiaoli

American Journal of Physiology-Lung Cellular and Molecular Physiology | December 4, 2015 | Volume: 310 | Issue: 5 | Pages: L452-L464

10.1152/ajplung.00089.2015 | PMID 26637632 Get It

Alveolar epithelial and endothelial cell injury is a major feature of the acute respiratory distress syndrome, in particular when in conjunction with ventilation therapies. Previously we showed [Kim SC, Kellett T, Wang S, Nishi M, Nagre N, Zhou B, Flodby P, Shilo K, Ghadiali SN, Takeshima H, Hubmayr RD, Zhao X. Am J Physiol Lung Cell Mol Physiol 307: L449–L459, 2014.] that tripartite motif protein 72 (TRIM72) is essential for amending alveolar epithelial cell injury. Here, we posit that TRIM72 improves cellular integrity through its interaction with caveolin 1 (Cav1). Our data show that, in primary type I alveolar epithelial cells, lack of TRIM72 led to significant reduction of Cav1 at the plasma membrane, accompanied by marked attenuation of caveolar endocytosis. Meanwhile, lentivirus-mediated overexpression of TRIM72 selectively increases caveolar endocytosis in rat lung epithelial cells, suggesting a functional association between these two. Further coimmunoprecipitation assays show that deletion of either functional domain of TRIM72, i.e., RING, B-box, coiled-coil, or PRY-SPRY, abolishes the physical interaction between TRIM72 and Cav1, suggesting that all theoretical domains of TRIM72 are required to forge a strong interaction between these two molecules. Moreover, in vivo studies showed that injurious ventilation-induced lung cell death was significantly increased in knockout (KO) TRIM72KO and Cav1KO lungs compared with wild-type controls and was particularly pronounced in double KO mutants. Apoptosis was accompanied by accentuation of gross lung injury manifestations in the TRIM72KO and Cav1KO mice. Our data show that TRIM72 directly and indirectly modulates caveolar endocytosis, an essential process involved in repair of lung epithelial cells through removal of plasma membrane wounds. Given TRIM72's role in endomembrane trafficking and cell repair, we consider this molecule an attractive therapeutic target for patients with injured lungs.
Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community
Petersen, Ronald C. , Wiste, Heather J. , Weigand, Stephen D. , Rocca, Walter A. , Roberts, Rosebud O., Lowe, Val J. , Geda, Yonas E. , Jack, Clifford R. , Mielke, Michelle M. , Knopman, David S. , Pankratz, V. Shane , Machulda, Mary M. , Jack, Clifford R , Geda, Yonas E

JAMA Neurology | November 23, 2015 | Volume: 73 | Issue: 1 | Pages: 85

10.1001/jamaneurol.2015.3098 | PMID 26595683 Get It

Influence of amyloid and APOE on cognitive performance in a late middle‐aged cohort
Mielke, Michelle M. , Hagen, Clinton E., Christianson, Teresa J., Roberts, Rosebud O., Vemuri, Prashanthi , Lowe, Val J. , Kremers, Walter K. , Jack, Clifford R. , Petersen, Ronald C. , Machulda, Mary M. , Knopman, David S. , Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Kremers, Walter K

Alzheimer's & Dementia | November 19, 2015 | Volume: 12 | Issue: 3 | Pages: 281-291

10.1016/j.jalz.2015.09.010 | PMID 26602629 Get It

AbstractIntroductionFew studies have examined the effects of amyloid and apolipoprotein E (APOE) genotype on cognition among middle‐aged individuals.MethodsWe included 464 cognitively normal, test‐naïve, participants with Pittsburgh compound B positron emission tomography amyloid imaging, mean age of 62.7 (range, 51–71 years), enrolled in the Mayo Clinic Study of Aging. Participants completed multiple cognitive assessments, including a standard neuropsychological battery and the CogState computerized battery, over 30 months of follow‐up. Linear mixed models were used to examine the effects of amyloid and APOE genotype on baseline cognition and cognitive decline.ResultsElevated amyloid was not associated with tests of episodic memory but did predict declines on tests of executive function. APOE genotype was not associated with cognition. Among APOE ɛ4 noncarriers, higher amyloid was predictive of decline on tests of executive function and on one episodic memory test.DiscussionElevated amyloidosis and APOE genotype do not appear to exert a dramatic influence on cognition in middle age.
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS)
Investigators, The Huntington Study Group PHAROS, Biglan, Kevin , Shoulson, Ira , Kieburtz, Karl , Oakes, David , Kayson, Elise, Shinaman, M. Aileen, Zhao, Hongwei , Romer, Megan, Young, Anne B., Hersch, Steven M. , Penney, Jack, Marder, Karen, Paulsen, Jane S. , Quaid, Kimberly A., Siemers, Eric , Mallonee, William, Suter, Greg, Dubinsky, Richard , Nance, Martha , Bundlie, Scott R., Radtke, Dawn, Kostyk, Sandra K. , Baic, Corrine, Walker, Francis O. , Hunt, Victoria, Chouinard, Sylvain, Wood‐Siverio, Cathy, Corey‐Bloom, Jody , Peavy, Guerry M. , Moskowitz, Carol, Wesson, Melissa, Samii, Ali, Bird, Thomas D. , Lipe, Hillary, Blindauer, Karen, Marshall, Frederick J., Zimmerman, Carol, Goldstein, Jody, Rosas, Diana, Novák, Péter , Caviness, John N., Duffy, Amy, Wheelock, Vicki, Tempkin, Teresa, Seeberger, Lauren , Albin, Roger L. , Racette, Brad A. , Perlman, Susan , Bordelon, Yvette , Martin, W. R. Wayne , Wieler, Marguerite , Raymond, Lynn A. , Decolongon, Joji, Hunter, Christine , Hauser, Robert A. , Furtado, Sarah , Suchowersky, Oksana , Klimek, Mary Lou, Guttman, Mark, Sethna, Rustom, Feigin, Andrew, Cox, Marie, Shannon, Barbara , Percy, Alan K. , Dure, Leon , Harrison, Madaline B. , Higgins, Donald S. , Molho, Eric , Nickerson, Constance, Evans, Sharon, Hobson, Douglas, Singer, Carlos , Gálvez-Jiménez, Néstor, Shannon, Kathleen M. , Comella, Cynthia , Ross, Christopher A. , Hogarth, Penelope , Weiner, William J., Como, Peter G., Kumar, Rajeev , Cotto, Candace, Stout, Julie C. , Brocht, Alicia, Watts, Arthur, Eberly, Shirley , Weaver, Christine , Gusella, James F. , MacDonald, Marcy E., Fahn, Stanley, Shults, Clifford W., Caviness, John, Investigators, The Huntington Study Group PHAROS, Tanner, Caroline M. , Gray, Carolyn Steele , Baic, Corrine L., Caress, James B. , O’Neill, Christine J. , Factor, Stewart Alan , Greenamyre, J. Timothy , Song, David , Adler, Charles H. , Richman, David P. , Chou, Kelvin L. , Perlmutter, Joel S. , Leavitt, Blair R. , Clarke, Lorne A. , Jankovic, Joseph J. , Sanchez‐Ramos, Juan , Johnson, William , Saint‐Hilaire, Marie , Testa, Claudia M. , Rosenblatt, Adam E , Foroud, Tatiana , Myers, Richard H. , Ross, Christopher A , Hauser, Robert A

JAMA Neurology | November 16, 2015 | Volume: 73 | Issue: 1 | Pages: 102

10.1001/jamaneurol.2015.2736 | PMID 26569098 Get It

Prognostic value of p16 expression in Epstein‐Barr virus–positive nasopharyngeal carcinomas
Jiang, Wen , Chamberlain, Paul , Garden, Adam S. , Kim, Betty Y.S. , Ma, Dominic , Lo, Emily J., Bell, Diana , Gunn, G. Brandon , Fuller, Clifton D. , Rosenthal, David I. , Beadle, Beth M. , Frank, Steven J. , Morrison, William H. , Glisson, Bonnie S. , Phan, Jack , El‐Naggar, Adel K. , Sturgis, Erich M. , Jiang, Wen , Kim, Betty Y S , Phan, Jack , Fuller, Clifton David

Head & Neck | November 11, 2015 | Volume: 38 | Issue: S1 | Pages: No page available

10.1002/hed.24258 | PMID 26560893 Get It

AbstractBackgroundOverexpression of p16 is associated with improved outcomes among patients with oropharyngeal carcinoma. However, its role in the outcomes of patients with nasopharyngeal cancer (NPC) remains unclear.MethodsEighty‐six patients with NPC treated at MD Anderson Cancer Center from 2000 to 2014 were identified. Epstein‐Barr virus (EBV) and human papillomavirus (HPV) status were determined by in situ hybridization (ISH) and p16 by immunohistochemical staining.ResultsEBV positivity was associated with extended overall survival (OS; median, 95.0 vs 44.9 months; p < .004), progression‐free survival (PFS; median, 80.4 vs 28.1 months; p < .013), and locoregional control (median, 104.4 vs 65.5 months; p < .043). In patients with EBV‐positive tumors, p16 overexpression correlated with improved PFS (median, 106.3 vs 27.1 months; p < .02) and locoregional control (median, 93.6 vs 64.5 months; p < .02).ConclusionP16 overexpression is associated with improved PFS and locoregional control in patients with EBV‐positive NPC. P16 expression may complement EBV status in predicting treatment outcomes for patients with NPC. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1459–E1466, 2016
Laryngeal cryptococcosis: Literature review and guidelines for laser ablation of fungal lesions
Jeng, Jack Y., Tomblinson, Courtney M. , Ocal, Idris Tolgay, Vikram, Holenarasipur R. , Vikram, Holenarasipur R. , Lott, David G.

The Laryngoscope | November 4, 2015 | Volume: 126 | Issue: 7 | Pages: 1625-1629

10.1002/lary.25749 | PMID 26536499 Get It

Atrial fibrillation, cognitive impairment, and neuroimaging
Graff‐Radford, Jonathan , Madhavan, Malini , Vemuri, Prashanthi , Cha, Ruth H., Mielke, Michelle M. , Kantarci, Kejal , Lowe, Val J. , Senjem, Matthew L. , Gunter, Jeffrey L. , Petersen, Ronald C. , Jack, Clifford R. , Roberts, Rosebud O., Rabinstein, Alejandro A. , Cha, Ruth H., Knopman, David S. , Jack, Clifford R , Mielke, Michelle M , Vemuri, Prashanthi , Senjem, Matthew L , Kantarci, Kejal

Alzheimer's & Dementia | October 25, 2015 | Volume: 12 | Issue: 4 | Pages: 391-398

10.1016/j.jalz.2015.08.164 | PMID 26607820 Get It

AbstractIntroductionThe objective of our study was to investigate cross‐sectional associations of atrial fibrillation with neuroimaging measures of cerebrovascular disease and Alzheimer's disease and their interactions with mild cognitive impairment (MCI).MethodsMagnetic resonance imaging scans of individuals from a population‐based study were analyzed for infarctions, total gray matter, and hippocampal and white matter hyperintensity volumes. A subsample underwent positron emission tomography imaging.ResultsAtrial fibrillation was associated with infarctions and lower total gray matter volume. Compared with subjects with no atrial fibrillation and no infarction, the odds ratio (95% confidence intervals) for MCI was 2.99 (1.57–5.70; P = .001) among participants with atrial fibrillation and infarction, 0.90 (0.45–1.80; P = .77) for atrial fibrillation and no infarction, and 1.50 (0.96–2.34; P = .08) for no atrial fibrillation and any infarction.DiscussionParticipants with both atrial fibrillation and infarction are more likely to have MCI than participants with either infarction or atrial fibrillation alone.